Tarik Senussi

Snr Director of Process, Formulation Development & MSAT at Gyroscope Therapeutics

Tarik Senussi is the Director of process, formulation development & MSAT at Gyroscope Therapeutics Ltd a Novartis company. Tarik joined Gyroscope in February 2017, developing upstream and downstream processes for rAAV manufacture in suspension to support GT005 and other pipeline programmes. Prior to Joining Gyroscope Tarik was at GSK, establishing the upstream process development team to produce viral vectors and support the MMA for Strimvellis. Prior to that Tarik worked at Medimmune and Lonza Biologics. Tarik holds a BSc in Cell Biology and a PhD in Biochemical Engineering both from University College London.